FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2510117822> ?p ?o ?g. }

• W2510117822 endingPage "3671" @default.
• W2510117822 startingPage "3662" @default.
• W2510117822 abstract "We have analyzed factors influencing the outcome of 102 children with acute leukemia given a cord blood transplantation (CBT) and reported to the Eurocord Registry. Seventy patients with acute lymphoblastic and 32 with acute myeloid leukemia were given either a related (n = 42) or an unrelated (n = 60) CBT. Children given CBT during first or second complete remission were considered as belonging to the good-risk group (n = 66), whereas those who received a transplant in a more advanced stage of disease were assigned to the poor-risk group (n = 36). In the related group (RCBT), 12 of 42 patients received transplantation from an HLA-disparate donor, whereas in the unrelated group (UCBT) 54 of 60 received an HLA mismatched CBT. Kaplan-Meier estimates for neutrophil recovery at day 60 were 84% +/- 7% in RCBT and 79 +/- 6% in UCBT (P =.16). In multivariate analysis, the most important factor influencing neutrophil engraftment in UCBT was a nucleated cell dose infused greater than 3.7 x 10(7)/kg (P =.05, relative risk [RR] of 1.85, 95% confidence interval [CI]: 0.98-3.4). The incidence of grade II through IV acute graft-versus-host disease was 41% +/- 8% in the RCBT group and 37% +/- 6% in the UCBT group (P =.59). Kaplan-Meier estimates of 2-year event-free survival (EFS) after RCBT or UCBT were 39% +/- 8% and 30% +/- 7%, respectively (P =.19). In multivariate analysis, the most important factor influencing EFS was disease status at time of transplantation: good-risk patients had a 2-year EFS of 49% +/- 7% as compared to 8% +/- 5% in patients with more advanced disease (P =.0003, RR: 0.40, 95% CI: 0.24 to 0. 65). This was a consequence of both an increased 1-year transplant related mortality and a higher 2-year relapse rate in the poor-risk group (65% +/- 9% and 77% +/- 14%, respectively), as compared with good risk patients (34% +/- 6% and 31% +/- 9%, respectively). These data confirm that allogeneic CBT from either a related or an unrelated donor is a feasible procedure able to cure a significant proportion of children with acute leukemia, especially if transplanted in a favorable phase of disease." @default.
• W2510117822 created "2016-09-16" @default.
• W2510117822 creator A5000858647 @default.
• W2510117822 creator A5007202804 @default.
• W2510117822 creator A5021463812 @default.
• W2510117822 creator A5022712318 @default.
• W2510117822 creator A5027372921 @default.
• W2510117822 creator A5039519417 @default.
• W2510117822 creator A5047010545 @default.
• W2510117822 creator A5049735878 @default.
• W2510117822 creator A5053603003 @default.
• W2510117822 creator A5062679129 @default.
• W2510117822 creator A5070385433 @default.
• W2510117822 creator A5078260297 @default.
• W2510117822 creator A5083201664 @default.
• W2510117822 creator A5086618764 @default.
• W2510117822 creator A5087659468 @default.
• W2510117822 creator A5090289263 @default.
• W2510117822 date "1999-06-01" @default.
• W2510117822 modified "2023-09-27" @default.
• W2510117822 title "Factors Associated With Outcome After Cord Blood Transplantation in Children With Acute Leukemia" @default.
• W2510117822 cites W107716097 @default.
• W2510117822 cites W1274344746 @default.
• W2510117822 cites W1530764705 @default.
• W2510117822 cites W1545991364 @default.
• W2510117822 cites W1707184873 @default.
• W2510117822 cites W1963797542 @default.
• W2510117822 cites W1965979673 @default.
• W2510117822 cites W1985926641 @default.
• W2510117822 cites W2010055592 @default.
• W2510117822 cites W2038215542 @default.
• W2510117822 cites W2047779195 @default.
• W2510117822 cites W2052364047 @default.
• W2510117822 cites W2053278212 @default.
• W2510117822 cites W2054425626 @default.
• W2510117822 cites W2063142731 @default.
• W2510117822 cites W2070095638 @default.
• W2510117822 cites W2073328751 @default.
• W2510117822 cites W2085516849 @default.
• W2510117822 cites W2132672859 @default.
• W2510117822 cites W2155523847 @default.
• W2510117822 cites W2161394563 @default.
• W2510117822 cites W2204379292 @default.
• W2510117822 cites W2268274541 @default.
• W2510117822 cites W2304521922 @default.
• W2510117822 cites W2317117822 @default.
• W2510117822 cites W2330713242 @default.
• W2510117822 cites W2333162405 @default.
• W2510117822 cites W2335857054 @default.
• W2510117822 cites W2341215846 @default.
• W2510117822 cites W2345454632 @default.
• W2510117822 cites W2407208193 @default.
• W2510117822 cites W2407662173 @default.
• W2510117822 cites W2409904921 @default.
• W2510117822 cites W2412493071 @default.
• W2510117822 cites W2466495790 @default.
• W2510117822 cites W43502357 @default.
• W2510117822 cites W80850850 @default.
• W2510117822 cites W958622893 @default.
• W2510117822 doi "https://doi.org/10.1182/blood.v93.11.3662" @default.
• W2510117822 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10339472" @default.
• W2510117822 hasPublicationYear "1999" @default.
• W2510117822 type Work @default.
• W2510117822 sameAs 2510117822 @default.
• W2510117822 citedByCount "100" @default.
• W2510117822 countsByYear W25101178222012 @default.
• W2510117822 countsByYear W25101178222013 @default.
• W2510117822 countsByYear W25101178222014 @default.
• W2510117822 countsByYear W25101178222015 @default.
• W2510117822 countsByYear W25101178222016 @default.
• W2510117822 countsByYear W25101178222017 @default.
• W2510117822 countsByYear W25101178222020 @default.
• W2510117822 countsByYear W25101178222023 @default.
• W2510117822 crossrefType "journal-article" @default.
• W2510117822 hasAuthorship W2510117822A5000858647 @default.
• W2510117822 hasAuthorship W2510117822A5007202804 @default.
• W2510117822 hasAuthorship W2510117822A5021463812 @default.
• W2510117822 hasAuthorship W2510117822A5022712318 @default.
• W2510117822 hasAuthorship W2510117822A5027372921 @default.
• W2510117822 hasAuthorship W2510117822A5039519417 @default.
• W2510117822 hasAuthorship W2510117822A5047010545 @default.
• W2510117822 hasAuthorship W2510117822A5049735878 @default.
• W2510117822 hasAuthorship W2510117822A5053603003 @default.
• W2510117822 hasAuthorship W2510117822A5062679129 @default.
• W2510117822 hasAuthorship W2510117822A5070385433 @default.
• W2510117822 hasAuthorship W2510117822A5078260297 @default.
• W2510117822 hasAuthorship W2510117822A5083201664 @default.
• W2510117822 hasAuthorship W2510117822A5086618764 @default.
• W2510117822 hasAuthorship W2510117822A5087659468 @default.
• W2510117822 hasAuthorship W2510117822A5090289263 @default.
• W2510117822 hasConcept C120665830 @default.
• W2510117822 hasConcept C121332964 @default.
• W2510117822 hasConcept C126322002 @default.
• W2510117822 hasConcept C141071460 @default.
• W2510117822 hasConcept C2776863199 @default.
• W2510117822 hasConcept C2778461978 @default.
• W2510117822 hasConcept C2778729363 @default.
• W2510117822 hasConcept C2911091166 @default.

• next